Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with Three New Concentrations

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today the launch of ADRENALIN® (epinephrine in 0.9% sodium ...
Princeton University

Outdoor Action Guide to

Traveling in cold weather conditions can be life threatening. The information provided here is designed for educational use only and is not a substitute for specific training or experience. Princeton ...
Finanznachrichten

Alnylam Pharmaceuticals, Inc.: Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology ...

- Company to Webcast Investor Event on August 30, 2025, at 1:00 p.m. EDT (7:00 pm CEST)- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the ...